Literature DB >> 9101082

Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines.

S Timmermann1, P W Hinds, K Münger.   

Abstract

We have investigated the functional integrity of the retinoblastoma tumor suppressor pathway in five human squamous cell carcinoma lines. Elevated activity of cyclin-dependent kinase 6 (cdk6), a pRB kinase, was detected in all five squamous cell carcinoma lines. Overexpression of the cdk6 protein was detected in one of the five cell lines. The cdk6-specific inhibitor p18ink4C is expressed and associated with cdk6 in all five squamous cell carcinoma lines. In contrast, only very low levels of p16ink4A were detected in these cell lines. This may contribute to the elevated activity of cdk6 in these lines. Elevated activity of cdk6 may result in hyperphosphorylation of the retinoblastoma protein and, therefore, compromise its negative growth-regulatory activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9101082

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  12 in total

Review 1.  Targeting CDK6 in cancer: State of the art and new insights.

Authors:  Solomon Tadesse; Mingfeng Yu; Malika Kumarasiri; Bich Thuy Le; Shudong Wang
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Kinase requirements in human cells: II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells.

Authors:  Amy Baldwin; Wenliang Li; Miranda Grace; Joseph Pearlberg; Ed Harlow; Karl Münger; Dorre A Grueneberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-23       Impact factor: 11.205

3.  Unexpected reduction of skin tumorigenesis on expression of cyclin-dependent kinase 6 in mouse epidermis.

Authors:  Xian Wang; Christopher Sistrunk; Marcelo L Rodriguez-Puebla
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

4.  Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity.

Authors:  Jennelle C Hodge; Tae-Min Kim; Jonathan M Dreyfuss; Priya Somasundaram; Nicole C Christacos; Marissa Rousselle; Bradley J Quade; Peter J Park; Elizabeth A Stewart; Cynthia C Morton
Journal:  Hum Mol Genet       Date:  2012-02-17       Impact factor: 6.150

Review 5.  Double edge: CDK2AP1 in cell-cycle regulation and epigenetic regulation.

Authors:  D T W Wong; J J Kim; O Khalid; H H Sun; Y Kim
Journal:  J Dent Res       Date:  2011-08-24       Impact factor: 6.116

6.  Distinct subcellular distribution of cyclin dependent kinase 6.

Authors:  Dawn M Kohrt; Jennifer I Crary; Vasilena Gocheva; Philip W Hinds; Martha J Grossel
Journal:  Cell Cycle       Date:  2009-09-14       Impact factor: 4.534

7.  A mouse model of human oral-esophageal cancer.

Authors:  Oliver G Opitz; Hideki Harada; Yasir Suliman; Ben Rhoades; Norman E Sharpless; Ralph Kent; Levy Kopelovich; Hiroshi Nakagawa; Anil K Rustgi
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

8.  TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression.

Authors:  Youhna M Ayala; Tom Misteli; Francisco E Baralle
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-27       Impact factor: 11.205

9.  Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.

Authors:  M Sartor; H Steingrimsdottir; F Elamin; J Gäken; S Warnakulasuriya; M Partridge; N Thakker; N W Johnson; M Tavassoli
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

10.  Modulated expression of genes encoding estrogen metabolizing enzymes by G1-phase cyclin-dependent kinases 6 and 4 in human breast cancer cells.

Authors:  Yi Jia; Joanne Domenico; Christina Swasey; Meiqin Wang; Erwin W Gelfand; Joseph J Lucas
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.